nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—Topoisomerase Inhibitors—Etoposide—peripheral nervous system neoplasm	0.286	0.43	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Epirubicin—peripheral nervous system neoplasm	0.197	0.296	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Doxorubicin—peripheral nervous system neoplasm	0.182	0.274	CiPCiCtD
Topotecan—ABCB1—peripheral nervous system neoplasm	0.126	1	CbGaD
Topotecan—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0265	0.185	CbGbCtD
Topotecan—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0163	0.114	CbGbCtD
Topotecan—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0152	0.106	CbGbCtD
Topotecan—ABCG2—Etoposide—peripheral nervous system neoplasm	0.015	0.104	CbGbCtD
Topotecan—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0138	0.096	CbGbCtD
Topotecan—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0102	0.071	CbGbCtD
Topotecan—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00957	0.0665	CbGbCtD
Topotecan—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00769	0.0535	CbGbCtD
Topotecan—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00589	0.041	CbGbCtD
Topotecan—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00549	0.0382	CbGbCtD
Topotecan—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0054	0.0375	CbGbCtD
Topotecan—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00368	0.0256	CbGbCtD
Topotecan—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00353	0.0245	CbGbCtD
Topotecan—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00323	0.0225	CbGbCtD
Topotecan—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00221	0.0153	CbGbCtD
Topotecan—Irinotecan—BCHE—peripheral nervous system neoplasm	0.00121	0.718	CrCbGaD
Topotecan—Irinotecan—ABCB1—peripheral nervous system neoplasm	0.000475	0.281	CrCbGaD
Topotecan—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	5.98e-05	0.00095	CcSEcCtD
Topotecan—Leukopenia—Etoposide—peripheral nervous system neoplasm	5.94e-05	0.000944	CcSEcCtD
Topotecan—Pain—Alitretinoin—peripheral nervous system neoplasm	5.93e-05	0.000943	CcSEcCtD
Topotecan—Constipation—Alitretinoin—peripheral nervous system neoplasm	5.93e-05	0.000943	CcSEcCtD
Topotecan—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	5.92e-05	0.00094	CcSEcCtD
Topotecan—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	5.92e-05	0.00094	CcSEcCtD
Topotecan—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	5.91e-05	0.000939	CcSEcCtD
Topotecan—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	5.91e-05	0.000938	CcSEcCtD
Topotecan—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	5.87e-05	0.000933	CcSEcCtD
Topotecan—Infection—Cisplatin—peripheral nervous system neoplasm	5.87e-05	0.000933	CcSEcCtD
Topotecan—Lethargy—Doxorubicin—peripheral nervous system neoplasm	5.83e-05	0.000927	CcSEcCtD
Topotecan—Vomiting—Isotretinoin—peripheral nervous system neoplasm	5.82e-05	0.000925	CcSEcCtD
Topotecan—Vomiting—Tretinoin—peripheral nervous system neoplasm	5.82e-05	0.000925	CcSEcCtD
Topotecan—Decreased appetite—Vincristine—peripheral nervous system neoplasm	5.81e-05	0.000924	CcSEcCtD
Topotecan—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	5.8e-05	0.000921	CcSEcCtD
Topotecan—Cough—Etoposide—peripheral nervous system neoplasm	5.79e-05	0.00092	CcSEcCtD
Topotecan—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	5.79e-05	0.00092	CcSEcCtD
Topotecan—Rash—Tretinoin—peripheral nervous system neoplasm	5.77e-05	0.000917	CcSEcCtD
Topotecan—Rash—Isotretinoin—peripheral nervous system neoplasm	5.77e-05	0.000917	CcSEcCtD
Topotecan—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	5.77e-05	0.000917	CcSEcCtD
Topotecan—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	5.77e-05	0.000916	CcSEcCtD
Topotecan—Dermatitis—Tretinoin—peripheral nervous system neoplasm	5.77e-05	0.000916	CcSEcCtD
Topotecan—Fatigue—Vincristine—peripheral nervous system neoplasm	5.76e-05	0.000916	CcSEcCtD
Topotecan—Vomiting—Melphalan—peripheral nervous system neoplasm	5.75e-05	0.000913	CcSEcCtD
Topotecan—Skin disorder—Cisplatin—peripheral nervous system neoplasm	5.74e-05	0.000912	CcSEcCtD
Topotecan—Headache—Tretinoin—peripheral nervous system neoplasm	5.74e-05	0.000911	CcSEcCtD
Topotecan—Headache—Isotretinoin—peripheral nervous system neoplasm	5.74e-05	0.000911	CcSEcCtD
Topotecan—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	5.72e-05	0.000909	CcSEcCtD
Topotecan—Pain—Vincristine—peripheral nervous system neoplasm	5.72e-05	0.000908	CcSEcCtD
Topotecan—Constipation—Vincristine—peripheral nervous system neoplasm	5.72e-05	0.000908	CcSEcCtD
Topotecan—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	5.72e-05	0.000908	CcSEcCtD
Topotecan—Rash—Melphalan—peripheral nervous system neoplasm	5.7e-05	0.000905	CcSEcCtD
Topotecan—Dermatitis—Melphalan—peripheral nervous system neoplasm	5.69e-05	0.000905	CcSEcCtD
Topotecan—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	5.67e-05	0.000902	CcSEcCtD
Topotecan—Chest pain—Etoposide—peripheral nervous system neoplasm	5.65e-05	0.000898	CcSEcCtD
Topotecan—Anorexia—Cisplatin—peripheral nervous system neoplasm	5.64e-05	0.000895	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	5.61e-05	0.000892	CcSEcCtD
Topotecan—Discomfort—Etoposide—peripheral nervous system neoplasm	5.58e-05	0.000887	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	5.56e-05	0.000884	CcSEcCtD
Topotecan—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	5.51e-05	0.000876	CcSEcCtD
Topotecan—Urticaria—Alitretinoin—peripheral nervous system neoplasm	5.51e-05	0.000876	CcSEcCtD
Topotecan—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	5.48e-05	0.000872	CcSEcCtD
Topotecan—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	5.48e-05	0.000872	CcSEcCtD
Topotecan—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	5.47e-05	0.000869	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	5.45e-05	0.000866	CcSEcCtD
Topotecan—Nausea—Tretinoin—peripheral nervous system neoplasm	5.44e-05	0.000864	CcSEcCtD
Topotecan—Nausea—Isotretinoin—peripheral nervous system neoplasm	5.44e-05	0.000864	CcSEcCtD
Topotecan—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	5.43e-05	0.000864	CcSEcCtD
Topotecan—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	5.42e-05	0.000861	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	5.39e-05	0.000856	CcSEcCtD
Topotecan—Infection—Etoposide—peripheral nervous system neoplasm	5.38e-05	0.000855	CcSEcCtD
Topotecan—Asthenia—Dactinomycin—peripheral nervous system neoplasm	5.37e-05	0.000853	CcSEcCtD
Topotecan—Nausea—Melphalan—peripheral nervous system neoplasm	5.37e-05	0.000853	CcSEcCtD
Topotecan—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	5.31e-05	0.000843	CcSEcCtD
Topotecan—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	5.3e-05	0.000843	CcSEcCtD
Topotecan—Abdominal pain—Vincristine—peripheral nervous system neoplasm	5.29e-05	0.00084	CcSEcCtD
Topotecan—Body temperature increased—Vincristine—peripheral nervous system neoplasm	5.29e-05	0.00084	CcSEcCtD
Topotecan—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	5.27e-05	0.000837	CcSEcCtD
Topotecan—Skin disorder—Etoposide—peripheral nervous system neoplasm	5.26e-05	0.000836	CcSEcCtD
Topotecan—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	5.24e-05	0.000832	CcSEcCtD
Topotecan—Anorexia—Etoposide—peripheral nervous system neoplasm	5.16e-05	0.00082	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	5.15e-05	0.000818	CcSEcCtD
Topotecan—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	5.14e-05	0.000817	CcSEcCtD
Topotecan—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	5.12e-05	0.000814	CcSEcCtD
Topotecan—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	5.11e-05	0.000812	CcSEcCtD
Topotecan—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	5.1e-05	0.000811	CcSEcCtD
Topotecan—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	5.07e-05	0.000806	CcSEcCtD
Topotecan—Pain—Cisplatin—peripheral nervous system neoplasm	5.06e-05	0.000803	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	5.04e-05	0.000801	CcSEcCtD
Topotecan—Neutropenia—Epirubicin—peripheral nervous system neoplasm	4.99e-05	0.000793	CcSEcCtD
Topotecan—Asthenia—Alitretinoin—peripheral nervous system neoplasm	4.98e-05	0.000791	CcSEcCtD
Topotecan—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	4.93e-05	0.000783	CcSEcCtD
Topotecan—Pruritus—Alitretinoin—peripheral nervous system neoplasm	4.91e-05	0.00078	CcSEcCtD
Topotecan—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	4.87e-05	0.000774	CcSEcCtD
Topotecan—Paraesthesia—Etoposide—peripheral nervous system neoplasm	4.86e-05	0.000773	CcSEcCtD
Topotecan—Weight increased—Epirubicin—peripheral nervous system neoplasm	4.86e-05	0.000772	CcSEcCtD
Topotecan—Dyspnoea—Etoposide—peripheral nervous system neoplasm	4.83e-05	0.000767	CcSEcCtD
Topotecan—Asthenia—Vincristine—peripheral nervous system neoplasm	4.8e-05	0.000762	CcSEcCtD
Topotecan—Pneumonia—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000761	CcSEcCtD
Topotecan—Infestation—Epirubicin—peripheral nervous system neoplasm	4.76e-05	0.000756	CcSEcCtD
Topotecan—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	4.76e-05	0.000756	CcSEcCtD
Topotecan—Vomiting—Dactinomycin—peripheral nervous system neoplasm	4.76e-05	0.000756	CcSEcCtD
Topotecan—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	4.75e-05	0.000754	CcSEcCtD
Topotecan—Rash—Dactinomycin—peripheral nervous system neoplasm	4.72e-05	0.00075	CcSEcCtD
Topotecan—Decreased appetite—Etoposide—peripheral nervous system neoplasm	4.71e-05	0.000748	CcSEcCtD
Topotecan—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	4.69e-05	0.000745	CcSEcCtD
Topotecan—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	4.68e-05	0.000743	CcSEcCtD
Topotecan—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	4.67e-05	0.000743	CcSEcCtD
Topotecan—Fatigue—Etoposide—peripheral nervous system neoplasm	4.67e-05	0.000742	CcSEcCtD
Topotecan—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	4.67e-05	0.000741	CcSEcCtD
Topotecan—Stomatitis—Epirubicin—peripheral nervous system neoplasm	4.64e-05	0.000737	CcSEcCtD
Topotecan—Pain—Etoposide—peripheral nervous system neoplasm	4.63e-05	0.000736	CcSEcCtD
Topotecan—Constipation—Etoposide—peripheral nervous system neoplasm	4.63e-05	0.000736	CcSEcCtD
Topotecan—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	4.62e-05	0.000734	CcSEcCtD
Topotecan—Dizziness—Alitretinoin—peripheral nervous system neoplasm	4.59e-05	0.000729	CcSEcCtD
Topotecan—Diarrhoea—Vincristine—peripheral nervous system neoplasm	4.57e-05	0.000727	CcSEcCtD
Topotecan—Sweating—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.000725	CcSEcCtD
Topotecan—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	4.5e-05	0.000715	CcSEcCtD
Topotecan—Weight increased—Doxorubicin—peripheral nervous system neoplasm	4.5e-05	0.000714	CcSEcCtD
Topotecan—Epistaxis—Epirubicin—peripheral nervous system neoplasm	4.49e-05	0.000713	CcSEcCtD
Topotecan—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	4.46e-05	0.000709	CcSEcCtD
Topotecan—Nausea—Dactinomycin—peripheral nervous system neoplasm	4.44e-05	0.000706	CcSEcCtD
Topotecan—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000704	CcSEcCtD
Topotecan—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	4.43e-05	0.000704	CcSEcCtD
Topotecan—Dizziness—Vincristine—peripheral nervous system neoplasm	4.42e-05	0.000703	CcSEcCtD
Topotecan—Vomiting—Alitretinoin—peripheral nervous system neoplasm	4.41e-05	0.000701	CcSEcCtD
Topotecan—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	4.4e-05	0.0007	CcSEcCtD
Topotecan—Infestation—Doxorubicin—peripheral nervous system neoplasm	4.4e-05	0.0007	CcSEcCtD
Topotecan—Rash—Alitretinoin—peripheral nervous system neoplasm	4.37e-05	0.000695	CcSEcCtD
Topotecan—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	4.37e-05	0.000694	CcSEcCtD
Topotecan—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	4.36e-05	0.000692	CcSEcCtD
Topotecan—Headache—Alitretinoin—peripheral nervous system neoplasm	4.35e-05	0.000691	CcSEcCtD
Topotecan—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	4.32e-05	0.000686	CcSEcCtD
Topotecan—Urticaria—Etoposide—peripheral nervous system neoplasm	4.3e-05	0.000684	CcSEcCtD
Topotecan—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	4.29e-05	0.000682	CcSEcCtD
Topotecan—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	4.29e-05	0.000682	CcSEcCtD
Topotecan—Rhinitis—Epirubicin—peripheral nervous system neoplasm	4.28e-05	0.000681	CcSEcCtD
Topotecan—Body temperature increased—Etoposide—peripheral nervous system neoplasm	4.28e-05	0.00068	CcSEcCtD
Topotecan—Abdominal pain—Etoposide—peripheral nervous system neoplasm	4.28e-05	0.00068	CcSEcCtD
Topotecan—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	4.27e-05	0.000679	CcSEcCtD
Topotecan—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	4.25e-05	0.000676	CcSEcCtD
Topotecan—Vomiting—Vincristine—peripheral nervous system neoplasm	4.25e-05	0.000675	CcSEcCtD
Topotecan—Asthenia—Cisplatin—peripheral nervous system neoplasm	4.24e-05	0.000674	CcSEcCtD
Topotecan—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	4.24e-05	0.000674	CcSEcCtD
Topotecan—Sweating—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000671	CcSEcCtD
Topotecan—Rash—Vincristine—peripheral nervous system neoplasm	4.22e-05	0.00067	CcSEcCtD
Topotecan—Dermatitis—Vincristine—peripheral nervous system neoplasm	4.21e-05	0.000669	CcSEcCtD
Topotecan—Headache—Vincristine—peripheral nervous system neoplasm	4.19e-05	0.000666	CcSEcCtD
Topotecan—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	4.17e-05	0.000662	CcSEcCtD
Topotecan—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	4.15e-05	0.00066	CcSEcCtD
Topotecan—Nausea—Alitretinoin—peripheral nervous system neoplasm	4.12e-05	0.000655	CcSEcCtD
Topotecan—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	4.04e-05	0.000643	CcSEcCtD
Topotecan—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	3.99e-05	0.000634	CcSEcCtD
Topotecan—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	3.97e-05	0.000631	CcSEcCtD
Topotecan—Nausea—Vincristine—peripheral nervous system neoplasm	3.97e-05	0.000631	CcSEcCtD
Topotecan—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	3.96e-05	0.00063	CcSEcCtD
Topotecan—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	3.95e-05	0.000628	CcSEcCtD
Topotecan—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	3.93e-05	0.000625	CcSEcCtD
Topotecan—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	3.92e-05	0.000624	CcSEcCtD
Topotecan—Asthenia—Etoposide—peripheral nervous system neoplasm	3.89e-05	0.000617	CcSEcCtD
Topotecan—Angiopathy—Epirubicin—peripheral nervous system neoplasm	3.88e-05	0.000616	CcSEcCtD
Topotecan—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	3.86e-05	0.000613	CcSEcCtD
Topotecan—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	3.85e-05	0.000612	CcSEcCtD
Topotecan—Chills—Epirubicin—peripheral nervous system neoplasm	3.83e-05	0.000609	CcSEcCtD
Topotecan—Pruritus—Etoposide—peripheral nervous system neoplasm	3.83e-05	0.000609	CcSEcCtD
Topotecan—Alopecia—Epirubicin—peripheral nervous system neoplasm	3.78e-05	0.0006	CcSEcCtD
Topotecan—Vomiting—Cisplatin—peripheral nervous system neoplasm	3.76e-05	0.000597	CcSEcCtD
Topotecan—Rash—Cisplatin—peripheral nervous system neoplasm	3.73e-05	0.000592	CcSEcCtD
Topotecan—Dermatitis—Cisplatin—peripheral nervous system neoplasm	3.72e-05	0.000592	CcSEcCtD
Topotecan—Malnutrition—Epirubicin—peripheral nervous system neoplasm	3.72e-05	0.000591	CcSEcCtD
Topotecan—Diarrhoea—Etoposide—peripheral nervous system neoplasm	3.71e-05	0.000589	CcSEcCtD
Topotecan—Back pain—Epirubicin—peripheral nervous system neoplasm	3.6e-05	0.000572	CcSEcCtD
Topotecan—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	3.59e-05	0.00057	CcSEcCtD
Topotecan—Dizziness—Etoposide—peripheral nervous system neoplasm	3.58e-05	0.000569	CcSEcCtD
Topotecan—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	3.58e-05	0.000568	CcSEcCtD
Topotecan—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	3.57e-05	0.000567	CcSEcCtD
Topotecan—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.56e-05	0.000566	CcSEcCtD
Topotecan—Chills—Doxorubicin—peripheral nervous system neoplasm	3.55e-05	0.000564	CcSEcCtD
Topotecan—Nausea—Cisplatin—peripheral nervous system neoplasm	3.51e-05	0.000558	CcSEcCtD
Topotecan—Alopecia—Doxorubicin—peripheral nervous system neoplasm	3.49e-05	0.000555	CcSEcCtD
Topotecan—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	3.45e-05	0.000548	CcSEcCtD
Topotecan—Vomiting—Etoposide—peripheral nervous system neoplasm	3.44e-05	0.000547	CcSEcCtD
Topotecan—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	3.44e-05	0.000547	CcSEcCtD
Topotecan—Anaemia—Epirubicin—peripheral nervous system neoplasm	3.44e-05	0.000546	CcSEcCtD
Topotecan—Rash—Etoposide—peripheral nervous system neoplasm	3.41e-05	0.000543	CcSEcCtD
Topotecan—Dermatitis—Etoposide—peripheral nervous system neoplasm	3.41e-05	0.000542	CcSEcCtD
Topotecan—Headache—Etoposide—peripheral nervous system neoplasm	3.39e-05	0.000539	CcSEcCtD
Topotecan—Malaise—Epirubicin—peripheral nervous system neoplasm	3.35e-05	0.000533	CcSEcCtD
Topotecan—Leukopenia—Epirubicin—peripheral nervous system neoplasm	3.33e-05	0.000529	CcSEcCtD
Topotecan—Back pain—Doxorubicin—peripheral nervous system neoplasm	3.33e-05	0.000529	CcSEcCtD
Topotecan—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	3.31e-05	0.000526	CcSEcCtD
Topotecan—Cough—Epirubicin—peripheral nervous system neoplasm	3.25e-05	0.000516	CcSEcCtD
Topotecan—Nausea—Etoposide—peripheral nervous system neoplasm	3.22e-05	0.000511	CcSEcCtD
Topotecan—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	3.19e-05	0.000507	CcSEcCtD
Topotecan—Anaemia—Doxorubicin—peripheral nervous system neoplasm	3.18e-05	0.000505	CcSEcCtD
Topotecan—Chest pain—Epirubicin—peripheral nervous system neoplasm	3.17e-05	0.000503	CcSEcCtD
Topotecan—Myalgia—Epirubicin—peripheral nervous system neoplasm	3.17e-05	0.000503	CcSEcCtD
Topotecan—Arthralgia—Epirubicin—peripheral nervous system neoplasm	3.17e-05	0.000503	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	3.15e-05	0.0005	CcSEcCtD
Topotecan—Discomfort—Epirubicin—peripheral nervous system neoplasm	3.13e-05	0.000497	CcSEcCtD
Topotecan—Malaise—Doxorubicin—peripheral nervous system neoplasm	3.1e-05	0.000493	CcSEcCtD
Topotecan—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	3.08e-05	0.00049	CcSEcCtD
Topotecan—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	3.04e-05	0.000482	CcSEcCtD
Topotecan—Infection—Epirubicin—peripheral nervous system neoplasm	3.02e-05	0.000479	CcSEcCtD
Topotecan—Cough—Doxorubicin—peripheral nervous system neoplasm	3e-05	0.000477	CcSEcCtD
Topotecan—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	2.98e-05	0.000473	CcSEcCtD
Topotecan—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	2.97e-05	0.000472	CcSEcCtD
Topotecan—Skin disorder—Epirubicin—peripheral nervous system neoplasm	2.95e-05	0.000469	CcSEcCtD
Topotecan—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	2.93e-05	0.000466	CcSEcCtD
Topotecan—Myalgia—Doxorubicin—peripheral nervous system neoplasm	2.93e-05	0.000466	CcSEcCtD
Topotecan—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	2.93e-05	0.000466	CcSEcCtD
Topotecan—Chest pain—Doxorubicin—peripheral nervous system neoplasm	2.93e-05	0.000466	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	2.91e-05	0.000462	CcSEcCtD
Topotecan—Discomfort—Doxorubicin—peripheral nervous system neoplasm	2.9e-05	0.00046	CcSEcCtD
Topotecan—Anorexia—Epirubicin—peripheral nervous system neoplasm	2.89e-05	0.00046	CcSEcCtD
Topotecan—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	2.81e-05	0.000446	CcSEcCtD
Topotecan—Infection—Doxorubicin—peripheral nervous system neoplasm	2.79e-05	0.000443	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	2.77e-05	0.00044	CcSEcCtD
Topotecan—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	2.75e-05	0.000438	CcSEcCtD
Topotecan—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	2.75e-05	0.000437	CcSEcCtD
Topotecan—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	2.73e-05	0.000434	CcSEcCtD
Topotecan—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	2.73e-05	0.000433	CcSEcCtD
Topotecan—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	2.72e-05	0.000431	CcSEcCtD
Topotecan—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	2.71e-05	0.00043	CcSEcCtD
Topotecan—Anorexia—Doxorubicin—peripheral nervous system neoplasm	2.68e-05	0.000425	CcSEcCtD
Topotecan—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	2.67e-05	0.000425	CcSEcCtD
Topotecan—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	2.64e-05	0.000419	CcSEcCtD
Topotecan—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	2.62e-05	0.000416	CcSEcCtD
Topotecan—Fatigue—Epirubicin—peripheral nervous system neoplasm	2.62e-05	0.000416	CcSEcCtD
Topotecan—Pain—Epirubicin—peripheral nervous system neoplasm	2.6e-05	0.000413	CcSEcCtD
Topotecan—Constipation—Epirubicin—peripheral nervous system neoplasm	2.6e-05	0.000413	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	2.56e-05	0.000407	CcSEcCtD
Topotecan—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	2.52e-05	0.000401	CcSEcCtD
Topotecan—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	2.5e-05	0.000398	CcSEcCtD
Topotecan—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	2.5e-05	0.000398	CcSEcCtD
Topotecan—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	2.48e-05	0.000394	CcSEcCtD
Topotecan—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	2.47e-05	0.000393	CcSEcCtD
Topotecan—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	2.44e-05	0.000388	CcSEcCtD
Topotecan—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	2.43e-05	0.000385	CcSEcCtD
Topotecan—Fatigue—Doxorubicin—peripheral nervous system neoplasm	2.42e-05	0.000385	CcSEcCtD
Topotecan—Urticaria—Epirubicin—peripheral nervous system neoplasm	2.41e-05	0.000383	CcSEcCtD
Topotecan—Constipation—Doxorubicin—peripheral nervous system neoplasm	2.4e-05	0.000382	CcSEcCtD
Topotecan—Pain—Doxorubicin—peripheral nervous system neoplasm	2.4e-05	0.000382	CcSEcCtD
Topotecan—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.4e-05	0.000381	CcSEcCtD
Topotecan—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	2.4e-05	0.000381	CcSEcCtD
Topotecan—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	2.31e-05	0.000368	CcSEcCtD
Topotecan—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	2.3e-05	0.000365	CcSEcCtD
Topotecan—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.24e-05	0.000355	CcSEcCtD
Topotecan—Urticaria—Doxorubicin—peripheral nervous system neoplasm	2.23e-05	0.000355	CcSEcCtD
Topotecan—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.22e-05	0.000353	CcSEcCtD
Topotecan—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.22e-05	0.000353	CcSEcCtD
Topotecan—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.18e-05	0.000346	CcSEcCtD
Topotecan—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.15e-05	0.000341	CcSEcCtD
Topotecan—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.08e-05	0.00033	CcSEcCtD
Topotecan—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.07e-05	0.000329	CcSEcCtD
Topotecan—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.02e-05	0.00032	CcSEcCtD
Topotecan—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.01e-05	0.000319	CcSEcCtD
Topotecan—Pruritus—Doxorubicin—peripheral nervous system neoplasm	1.99e-05	0.000316	CcSEcCtD
Topotecan—Vomiting—Epirubicin—peripheral nervous system neoplasm	1.93e-05	0.000307	CcSEcCtD
Topotecan—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	1.92e-05	0.000305	CcSEcCtD
Topotecan—Rash—Epirubicin—peripheral nervous system neoplasm	1.91e-05	0.000304	CcSEcCtD
Topotecan—Dermatitis—Epirubicin—peripheral nervous system neoplasm	1.91e-05	0.000304	CcSEcCtD
Topotecan—Headache—Epirubicin—peripheral nervous system neoplasm	1.9e-05	0.000302	CcSEcCtD
Topotecan—Dizziness—Doxorubicin—peripheral nervous system neoplasm	1.86e-05	0.000295	CcSEcCtD
Topotecan—Nausea—Epirubicin—peripheral nervous system neoplasm	1.8e-05	0.000287	CcSEcCtD
Topotecan—Vomiting—Doxorubicin—peripheral nervous system neoplasm	1.79e-05	0.000284	CcSEcCtD
Topotecan—Rash—Doxorubicin—peripheral nervous system neoplasm	1.77e-05	0.000281	CcSEcCtD
Topotecan—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	1.77e-05	0.000281	CcSEcCtD
Topotecan—Headache—Doxorubicin—peripheral nervous system neoplasm	1.76e-05	0.00028	CcSEcCtD
Topotecan—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.67e-05	0.000265	CcSEcCtD
